Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History is a research paper published in JNCI Journal of the National Cancer Institute (2020). On theSindex it has a DataRank of 0.648. It has been cited 74 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.648
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: U01CA12958
National Cancer Institute
Grant: U01CA199218
National Cancer Institute
Grant: P01CA154292
National Cancer Institute
Grant: U54CA163303
National Cancer Institute
Grant: HHSN261201100031C
National Institutes of Health
Grant: 3U54CA163303-05S1
Vermont PROSPR Research Center (VPRC)
National Institutes of Health
Grant: 2P01CA154292-11
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice
National Institutes of Health
Grant: 5U01CA199218-02
Comparative Modeling: Informing Breast Cancer Control Practice and Policy
FWCI
4.49
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
Additional file 1 of Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
Additional file 1 of A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score
Additional file 1 of A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score